{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:26:29Z","timestamp":1793748389628,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"45","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,25]]},"DOI":"10.1038\/s41388-026-03990-8","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:57:00Z","timestamp":1790963820000},"page":"4875-4887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TFAM loss drives oxaliplatin resistance by linking mtDNA release to STING\u2013TBK1-mediated lysophagy"],"prefix":"10.1038","volume":"45","author":[{"given":"Xiao-Xuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Rui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Ming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6440-0204","authenticated-orcid":false,"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"3990_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","volume":"404","author":"C Eng","year":"2024","unstructured":"Eng C, Yoshino T, Ru\u00edz-Garc\u00eda E, Mostafa N, Cann CG, O\u2019Brian B, et al. Colorectal cancer. Lancet (Lond, Engl). 2024;404:294\u2013310.","journal-title":"Lancet (Lond, Engl)"},{"key":"3990_CR2","doi-asserted-by":"crossref","unstructured":"Gmeiner WH. Recent advances in therapeutic strategies to improve colorectal cancer treatment. Cancers. 2024;16:1029.","DOI":"10.3390\/cancers16051029"},{"key":"3990_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1200\/JCO-25-00621","volume":"44","author":"T Iveson","year":"2026","unstructured":"Iveson T, Saunders MP, Kelly C, Kerr RS, Cassidy J, Hollander NH, et al. Three versus 6 months of adjuvant oxaliplatin-fluoropyrimidine chemotherapy for colorectal cancer: final results of SCOT-an international, randomized, phase III, noninferiority trial. J Clin Oncol : Off J Am Soc Clin Oncol. 2026;44:534\u20139.","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"key":"3990_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/TCRM.S3583","volume":"5","author":"P Comella","year":"2009","unstructured":"Comella P, Casaretti R, Sandomenico C, Avallone A, Franco L. Role of oxaliplatin in the treatment of colorectal cancer. Ther Clin Risk Manag. 2009;5:229\u201338.","journal-title":"Ther Clin Risk Manag"},{"key":"3990_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-022-00902-6","volume":"7","author":"Y Li","year":"2022","unstructured":"Li Y, Gan Y, Liu J, Li J, Zhou Z, Tian R, et al. Downregulation of MEIS1 mediated by ELFN1-AS1\/EZH2\/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer. Signal Transduct Target Ther. 2022;7:87.","journal-title":"Signal Transduct Target Ther"},{"key":"3990_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23923-1","volume":"12","author":"F Hu","year":"2021","unstructured":"Hu F, Song D, Yan Y, Huang C, Shen C, Lan J, et al. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nat Commun. 2021;12:3651.","journal-title":"Nat Commun"},{"key":"3990_CR7","doi-asserted-by":"crossref","unstructured":"Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 2025;78:101170.","DOI":"10.1016\/j.drup.2024.101170"},{"key":"3990_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02217-2","volume":"24","author":"P Zhao","year":"2025","unstructured":"Zhao P, Yin S, Qiu Y, Sun C, Yu H. Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance. Mol cancer. 2025;24:23.","journal-title":"Mol cancer"},{"key":"3990_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/15384047.2015.1017691","volume":"16","author":"W Liu","year":"2015","unstructured":"Liu W, Zhang Z, Zhang Y, Chen X, Guo S, Lei Y, et al. HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK\/ERK signaling pathway. Cancer Biol Ther. 2015;16:511\u20137.","journal-title":"Cancer Biol Ther"},{"key":"3990_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20:114\u201330.","journal-title":"Autophagy"},{"key":"3990_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41418-022-01107-8","volume":"30","author":"Z Gao","year":"2023","unstructured":"Gao Z, Li C, Sun H, Bian Y, Cui Z, Wang N, et al. N(6)-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors. Cell Death Differ. 2023;30:544\u201359.","journal-title":"Cell Death Differ"},{"key":"3990_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/sj.cdd.4402039","volume":"14","author":"MJ Abedin","year":"2007","unstructured":"Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 2007;14:500\u201310.","journal-title":"Cell Death Differ"},{"key":"3990_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","volume":"13","author":"H Chang","year":"2020","unstructured":"Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol. 2020;13:159.","journal-title":"J Hematol Oncol"},{"key":"3990_CR14","doi-asserted-by":"publisher","first-page":"e110293","DOI":"10.1371\/journal.pone.0110293","volume":"9","author":"J Ge","year":"2014","unstructured":"Ge J, Chen Z, Huang J, Chen J, Yuan W, Deng Z, et al. Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer. PloS one. 2014;9:e110293.","journal-title":"PloS one"},{"key":"3990_CR15","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1038\/s41401-023-01112-8","volume":"44","author":"HL Wang","year":"2023","unstructured":"Wang HL, Li JN, Kan WJ, Xu GY, Luo GH, Song N, et al. Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway. Acta Pharmacol Sin. 2023;44:2296\u2013306.","journal-title":"Acta Pharmacol Sin"},{"key":"3990_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.redox.2017.05.025","volume":"13","author":"D Shin","year":"2017","unstructured":"Shin D, Kim EH, Lee J, Roh JL. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems. Redox Biol. 2017;13:219\u201327.","journal-title":"Redox Biol"},{"key":"3990_CR17","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.ymthe.2023.05.015","volume":"31","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen YY, Gao GB, Zheng YH, Yu NN, Ouyang L, et al. Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase. Mol Ther J Am Soc Gene Ther. 2023;31:2169\u201387.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"3990_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"3990_CR19","doi-asserted-by":"crossref","unstructured":"Wang F, Salvati A, Boya P. Lysosome-dependent cell death and deregulated autophagy induced by amine-modified polystyrene nanoparticles. Open Biol. 2018;8:170271.","DOI":"10.1098\/rsob.170271"},{"key":"3990_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jmb.2019.08.010","volume":"432","author":"C Papadopoulos","year":"2020","unstructured":"Papadopoulos C, Kravic B, Meyer H. Repair or lysophagy: dealing with damaged lysosomes. J Mol Biol. 2020;432:231\u20139.","journal-title":"J Mol Biol"},{"key":"3990_CR21","first-page":"31","volume":"2","author":"R Halaby","year":"2019","unstructured":"Halaby R. Influence of lysosomal sequestration on multidrug resistance in cancer cells. Cancer Drug Resist (Alhambra, Calif). 2019;2:31\u201342.","journal-title":"Cancer Drug Resist (Alhambra, Calif)"},{"key":"3990_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56294-y","volume":"16","author":"NY Park","year":"2025","unstructured":"Park NY, Jo DS, Yang JY, Bae JE, Kim JB, Kim YH, et al. Activation of lysophagy by a TBK1-SCF(FBXO3)-TMEM192-TAX1BP1 axis in response to lysosomal damage. Nat Commun. 2025;16:1109.","journal-title":"Nat Commun"},{"key":"3990_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"KP Hopfner","year":"2020","unstructured":"Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol cell Biol. 2020;21:501\u201321.","journal-title":"Nat Rev Mol cell Biol"},{"key":"3990_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/0008-5472.CAN-25-1791","volume":"86","author":"F Khan","year":"2026","unstructured":"Khan F, Petrosyan E, Liu Y, Bahrami A, Taefi E, Geula C, et al. Microglial TBK1 signaling promotes breast cancer brain metastasis. Cancer Res. 2026;86:12\u201321.","journal-title":"Cancer Res"},{"key":"3990_CR25","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1038\/s41388-022-02365-z","volume":"41","author":"Y Li","year":"2022","unstructured":"Li Y, Yang Q, Chen H, Yang X, Han J, Yao X, et al. TFAM downregulation promotes autophagy and ESCC survival through mtDNA stress-mediated STING pathway. Oncogene. 2022;41:3735\u201346.","journal-title":"Oncogene"},{"key":"3990_CR26","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1038\/s41388-025-03467-0","volume":"44","author":"J Zhao","year":"2025","unstructured":"Zhao J, Cui M, Yao X, Jiang Z, Qi L, Chen J, et al. Targeting TFAM downregulation mediated mtDNA-NLRP3 pathway suppresses TAM infiltration and HCC progression. Oncogene. 2025;44:2956\u201369.","journal-title":"Oncogene"},{"key":"3990_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2518675122","volume":"122","author":"Y Wang","year":"2025","unstructured":"Wang Y, Huang ZJ, Yu NN, Liang JZ, Zeng YH, Zhao Q, et al. MLKL\/retromer axis controls PD-L1 recycling to compromise antitumor immunity during VCP inhibition-induced necroptosis. Proc Natl Acad Sci USA. 2025;122:e2518675122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3990_CR28","doi-asserted-by":"crossref","unstructured":"Ye T, Wu C, Na J, Liu X, Huang Y. Multi-pathway study for oxaliplatin resistance reduction. Curr Issues Mol Biol. 2025;47:172.","DOI":"10.3390\/cimb47030172"},{"key":"3990_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01293-x","volume":"8","author":"G Yamashita","year":"2022","unstructured":"Yamashita G, Takano N, Kazama H, Tsukahara K, Miyazawa K. p53 regulates lysosomal membrane permeabilization as well as cytoprotective autophagy in response to DNA-damaging drugs. Cell Death Discov. 2022;8:502.","journal-title":"Cell Death Discov"},{"key":"3990_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145706","volume":"319","author":"M Yang","year":"2025","unstructured":"Yang M, Sun L, Feng X, Xu W. Mitochondrial transcription factor a as a guardian of mitochondrial integrity and emerging therapeutic target in human diseases: a review. Int J Biol Macromol. 2025;319:145706.","journal-title":"Int J Biol Macromol"},{"key":"3990_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.tibs.2018.08.007","volume":"43","author":"TJ Nicholls","year":"2018","unstructured":"Nicholls TJ, Gustafsson CM. Separating and segregating the human mitochondrial genome. Trends Biochem Sci. 2018;43:869\u201381.","journal-title":"Trends Biochem Sci"},{"key":"3990_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00815-2","volume":"20","author":"S Quan","year":"2025","unstructured":"Quan S, Fu X, Cai H, Ren Z, Xu Y, Jia L. The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer\u2019s disease. Mol Neurodegener. 2025;20:25.","journal-title":"Mol Neurodegener"},{"key":"3990_CR33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s42255-021-00385-9","volume":"3","author":"HG Sprenger","year":"2021","unstructured":"Sprenger HG, MacVicar T, Bahat A, Fiedler KU, Hermans S, Ehrentraut D, et al. Cellular pyrimidine imbalance triggers mitochondrial DNA-dependent innate immunity. Nat Metab. 2021;3:636\u201350.","journal-title":"Nat Metab"},{"key":"3990_CR34","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2165\/00003495-200060040-00005","volume":"60","author":"CR Culy","year":"2000","unstructured":"Culy CR, Clemett D, Wiseman LR. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Drugs. 2000;60:895\u2013924.","journal-title":"Drugs"},{"key":"3990_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/1061186X.2025.2600679","volume":"34","author":"J Hu","year":"2026","unstructured":"Hu J, Tang Z, Beeraka NM, Xu R, Liu J, Zhao X, et al. Multi-pathway therapeutics in colorectal cancer: targeting EMT, CSCs, and non-apoptotic cell death for drug resistance reversal. J drug Target. 2026;34:939\u201360.","journal-title":"J drug Target"},{"key":"3990_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41419-025-07572-6","volume":"16","author":"J Yin","year":"2025","unstructured":"Yin J, Shao Y, Huang F, Hong Y, Wei W, Jiang C, et al. Peroxisomal membrane protein PMP70 confers drug resistance in colorectal cancer. Cell Death Dis. 2025;16:293.","journal-title":"Cell Death Dis"},{"key":"3990_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.486","volume":"5","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xu C, Yang X, Liu X, Guo Z, Lin X, et al. Glycerol-3-phosphate acyltransferase 3-mediated lipid droplets accumulation confers chemoresistance of colorectal cancer. MedComm. 2024;5:e486.","journal-title":"MedComm"},{"key":"3990_CR38","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s44319-025-00405-9","volume":"26","author":"O Scott","year":"2025","unstructured":"Scott O, Saran E, Freeman SA. The spectrum of lysosomal stress and damage responses: from mechanosensing to inflammation. EMBO Rep. 2025;26:1425\u201339.","journal-title":"EMBO Rep"},{"key":"3990_CR39","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1080\/15548627.2025.2483598","volume":"21","author":"Z Tian","year":"2025","unstructured":"Tian Z, Wu Y, Yi B, Li L, Liu Y, Zhang H, et al. ESCRT III-mediated lysosomal repair improve renal tubular cell injury in cisplatin-induced AKI. Autophagy. 2025;21:1927\u201344.","journal-title":"Autophagy"},{"key":"3990_CR40","doi-asserted-by":"publisher","first-page":"11176","DOI":"10.1158\/0008-5472.CAN-07-2333","volume":"67","author":"N Li","year":"2007","unstructured":"Li N, Zheng Y, Chen W, Wang C, Liu X, He W, et al. Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis. Cancer Res. 2007;67:11176\u201385.","journal-title":"Cancer Res"},{"key":"3990_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41580-022-00542-2","volume":"24","author":"JNS Vargas","year":"2023","unstructured":"Vargas JNS, Hamasaki M, Kawabata T, Youle RJ, Yoshimori T. The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol cell Biol. 2023;24:167\u201385.","journal-title":"Nat Rev Mol cell Biol"},{"key":"3990_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev-biochem-030222-102505","volume":"93","author":"H Meyer","year":"2024","unstructured":"Meyer H, Kravic B. The endo-lysosomal damage response. Annu Rev Biochem. 2024;93:367\u201387.","journal-title":"Annu Rev Biochem"},{"key":"3990_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520:553\u20137.","journal-title":"Nature"},{"key":"3990_CR44","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.aax0860","volume":"368","author":"G Desd\u00edn-Mic\u00f3","year":"2020","unstructured":"Desd\u00edn-Mic\u00f3 G, Soto-Heredero G, Aranda JF, Oller J, Carrasco E, Gaband\u00e9-Rodr\u00edguez E, et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Sci (N Y, NY). 2020;368:1371\u20136.","journal-title":"Sci (N Y, NY)"},{"key":"3990_CR45","doi-asserted-by":"crossref","unstructured":"Lu T, Zhang Z, Bi Z, Lan T, Zeng H, Liu Y, et al. TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway. J Immunother Cancer. 2023;11:e005430.","DOI":"10.1136\/jitc-2022-005430"},{"key":"3990_CR46","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106065","volume":"40","author":"J Tian","year":"2021","unstructured":"Tian J, Zhang D, Kurbatov V, Wang Q, Wang Y, Fang D, et al. 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING. EMBO J. 2021;40:e106065.","journal-title":"EMBO J"},{"key":"3990_CR47","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","volume":"607","author":"C Hong","year":"2022","unstructured":"Hong C, Schubert M, Tijhuis AE, Requesens M, Roorda M, van den Brink A, et al. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature. 2022;607:366\u201373.","journal-title":"Nature"},{"key":"3990_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152579","volume":"444","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Qi J, Lim CW, Kim JW, Kim B. Dual TBK1\/IKK\u03b5 inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro. Toxicology. 2020;444:152579.","journal-title":"Toxicology"},{"key":"3990_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13046-022-02352-y","volume":"41","author":"AP Runde","year":"2022","unstructured":"Runde AP, Mack R, Breslin JP, Zhang J. The role of TBK1 in cancer pathogenesis and anticancer immunity. J Exp Clin cancer Res : CR. 2022;41:135.","journal-title":"J Exp Clin cancer Res : CR"},{"key":"3990_CR50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","volume":"22","author":"M Labrie","year":"2022","unstructured":"Labrie M, Brugge JS, Mills GB, Zervantonakis IK. Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer. Nat Rev Cancer. 2022;22:323\u201339.","journal-title":"Nat Rev Cancer"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03990-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03990-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03990-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:03:15Z","timestamp":1793746995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03990-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":50,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2026,11,25]]}},"alternative-id":["3990"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03990-8","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The use of patient samples was approved by the Institutional Research Ethics Committee of Jinan University (Approval No. JNUKY-2023-0091), and informed consent was obtained from all participants. The animal study was approved by the Institutional Animal Care and Use Committee of Jinan University (Approval No. 20251211-05).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}